Wen Cao et al. 2024. Honokiol Mitigates Metabolic-Associated Fatty Liver Disease by Regulating Nrf2 and RIPK3 Signaling Pathways. Turkish Journal of Gastroenterology. 35, 7 (Apr. 2024), 551–559.